Ambulatory Blood Pressure Changes Following Initiation of Continuous Subcutaneous Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease
Background/Objectives: Cardiovascular autonomic dysfunction is common in advanced Parkinson’s disease (PD), but 24-h ambulatory blood pressure profiles after initiation of continuous subcutaneous foslevodopa/foscarbidopa have not been fully characterized. Methods: In this retrospective, single-center exploratory longitudinal study, 21 patients underwent ambulatory blood pressure monitoring at baseline, during the first week after maintenance-dose optimization, and at 1 and 6 months. Results: The prevalence of nocturnal hypertension differed across visits (90.5% at baseline; 68.4% at 6 months; global p = 0.033). Nighttime systolic and diastolic blood pressure were lower at 6 months, with significant global differences (p = 0.042 and p = 0.021), whereas daytime measures did not differ significantly. Significant global differences were found for 24-h systolic blood pressure standard deviation, coefficient of variation, and average real variability (p = 0.007, p = 0.037, and p = 0.010). Nocturnal exposure to mean arterial pressure > 100 mmHg decreased, whereas no statistically significant increases in exposure to mean arterial pressure < 65 mmHg or in the prevalence of orthostatic hypotension were detected. The prevalence of supine hypertension differed across visits (p = 0.048). Conclusions: Follow-up was characterized by lower nocturnal hypertensive burden and reduced systolic blood pressure variability, without a group-level signal of worsening orthostatic responses. Larger controlled studies are required to confirm these exploratory findings.
Authors
- Halina Bartosik-Psujek (ORCID: https://orcid.org/0000-0002-2860-6456)
- Izabella Tomaszewska-Lampart (ORCID: https://orcid.org/0000-0002-6114-6594)
- Marek Biesiadecki (ORCID: https://orcid.org/0000-0003-4303-4393)
- Katarzyna Koszarska
- Karolina Głowacka
- Aleksandra Kostek
Institutions
- University of Rzeszów (PL)
Publication Details
- Journal
- Biomedicines
- Published
- 2026-11-19
- DOI
- https://doi.org/10.3390/biomedicines14112680
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00